ArticleCancersPublished
Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Cancers
- Published
- Topic
- Clinical care
- Subject terms
- Lung cancer; efficacy; Crizotinib; Entrectinib; Population-adjusted Indirect Comparisons; Ros1 Fusion-positive; Repotrectinib
- PubMed ID
- 40075596
- PubMed Central ID
- PMC11899369
- Open access
- Yes, open
- Added to directory
- Source checked